A BILL 
To amend title XIX of the Social Security Act to remove 
direct sales of drugs near expiration during the COVID– 
19 emergency from the calculation of certain pricing 
metrics under the Medicaid program. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Surplus Utilization of 
4
Pharmaceutical Products Leveraged In Emergency Sce-
5
narios Act of 2020’’ or the ‘‘SUPPLIES Act of 2020’’. 
6
17:00 Sep 05, 2020
H8139
2 
•HR 8139 IH
SEC. 2. REMOVING DIRECT SALES OF DRUGS NEAR EXPIRA-
1
TION DURING THE COVID–19 EMERGENCY 
2
FROM THE CALCULATION OF CERTAIN PRIC-
3
ING METRICS UNDER THE MEDICAID PRO-
4
GRAM. 
5
(a) IN GENERAL.—Section 1927 of the Social Secu-
6
rity Act (42 U.S.C. 1396r–8) is amended— 
7
(1) in subsection (c)(1)(C)— 
8
(A) in clause (i)— 
9
(i) in subclause (V), by striking ‘‘and’’ 
10
at the end; 
11
(ii) in subclause (VI), by striking the 
12
period and inserting ‘‘; and’’; and 
13
(iii) by adding at the end the fol-
14
lowing new subclause: 
15
‘‘(VII) any prices charged with 
16
respect to the direct sale by a manu-
17
facturer of a short-dated drug (as de-
18
fined in clause (iv)) during the period 
19
beginning on the first day of the 
20
emergency period described in section 
21
1135(g)(1)(B) and ending on the date 
22
that is 6 months after the last day of 
23
such emergency period.’’; and 
24
(B) by adding at the end the following new 
25
clause: 
26
17:00 Sep 05, 2020
H8139
3 
•HR 8139 IH
‘‘(iv) 
SHORT-DATED
DRUG
DE-
1
FINED.— 
2
‘‘(I) IN GENERAL.—For purposes 
3
of clause (i)(VII), the term ‘short- 
4
dated drug’ means, in the case of a 
5
drug with an applicable shelf life (as 
6
defined in subclause (II))— 
7
‘‘(aa) of 1 year or greater, a 
8
drug expiring (as determined by 
9
the labeled expiration date) not 
10
later than 1 year after the date 
11
of sale of such drug; and 
12
‘‘(bb) of less than 1 year, a 
13
drug expiring (as determined by 
14
the labeled expiration date) not 
15
later than the end of the period 
16
beginning on the date of sale of 
17
such drug and ending on the date 
18
that is the number of days of the 
19
applicable shelf life of such drug 
20
after such date of sale. 
21
‘‘(II) 
APPLICABLE
SHELF 
22
LIFE.—The term ‘applicable shelf life’ 
23
means, with respect to a drug, 50 per-
24
cent of the number of days occurring 
25
17:00 Sep 05, 2020
H8139
4 
•HR 8139 IH
during the period beginning on the 
1
date such drug is manufactured and 
2
ending on the date such drug expires 
3
(as determined by the labeled expira-
4
tion date), rounded to the nearest 
5
whole day.’’; and 
6
(2) in subsection (k)(1)(B)— 
7
(A) in subclause (IV), by striking ‘‘and’’ at 
8
the end; 
9
(B) in subclause (V), by striking the period 
10
and inserting ‘‘; and’’; and 
11
(C) by adding at the end the following new 
12
subclause: 
13
‘‘(VI) any prices described in 
14
subsection (c)(1)(C)(i)(VII).’’. 
15
(b) OUTREACH
TO MANUFACTURERS.—The Sec-
16
retary of Health and Human Services shall notify drug 
17
manufacturers of the amendments made by subsection (a) 
18
through an electronic communication through MLN Con-
19
nects or such other method as determined appropriate by 
20
the Secretary. 
21
Æ 
17:00 Sep 05, 2020
H8139
